Article
Uncovering variable neoplasms between ATM protein-truncating and common missense variants using 394 694 UK Biobank exomes.
Genes, chromosomes & cancer - 1 Sept 2022
Jiang Xiao, O'Neill Amanda, Smith Katherine R, Lai Zhongwu, Carss Keren, Wang Quanli, Petrovski Slavé
Abstract excerpt
As an essential regulator of DNA damage, ataxia-telangiectasia mutated (ATM) gene has been widely studied in oncology. However, the independent effects of ATM missense variants and protein-truncating variants (PTVs) on neoplasms have not been heavily studied. Whole-exome sequencing data and the clinical health records of 394,694 UK Biobank European participants were used in this analysis. We mined genetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
